The American Diabetes Association (ADA) is proud to announce the recipients of the ADA’s four 2019 Professional Interest Group Awards. Individually and collectively, their exemplary leadership, mentorship and achievements have advanced the field of diabetes care and improved health outcomes for people with diabetes.
“The recipients of this year’s Professional Interest Group Awards have each made significant contributions to advancing our understanding of diabetes. Their innovative work has given us the tools to improve the lives of millions of people living with and affected by diabetes,” said William T. Cefalu, MD, Chief Scientific, Medical and Mission Officer of the ADA. “We congratulate each one of them on their extraordinary accomplishments and thank them for their ongoing commitment to improving the lives of people with diabetes.”
The following leaders will be recognized at the ADA’s 79th Scientific Sessions, to be held June 7-11, 2019, at the Moscone Convention Center in San Francisco. Award winners will present award lectures, as noted.
Richard R. Rubin Award
Frank J. Snoek, PhD
Professor and Head of the Department of Medical Psychology at Amsterdam University Medical Centers in Amsterdam, The Netherlands and Chair of the Diabetes Psychology Research Group
Richard R. Rubin Award Lecture: #DiabetesPsychologyMatters, Saturday, June 8
Roger Pecoraro Award
James S. Wrobel, DPM, MS
Clinical Associate Professor in the Division of Metabolism, Endocrinology, and Diabetes at the University of Michigan and Staff Podiatrist at the VA Ann Arbor Healthcare System in Ann Arbor, Michigan
Roger Pecoraro Award Lecture: Artificial Intelligence for Predicting Diabetes-Related Foot Ulcer Outcomes, Saturday, June 8
Norbert Freinkel Award
Assiamira Ferrara, MD, PhD
Associate Director of the Division of Research at Kaiser Permanente Northern California and Director of the Diabetes and Obesity Prevention Core at the Center for Diabetes Translation Research
Norbert Freinkel Award Lecture: Translating Research on Diabetes and Obesity in Pregnancy into Prevention, Sunday, June 9
Edwin Bierman Award
Peter Rossing, MD, DMSc
Head of Complications Research and Chief Physician at Steno Diabetes Center in Copenhagen, Denmark
Edwin Bierman Award Lecture: Linking Kidney and Cardiovascular Complications—Impact on Prognosis and Treatment, Monday, June 10
The American Diabetes Association’s 79th Scientific Sessions, the world’s largest scientific meeting focused on diabetes research, prevention and care, will be held June 7-11, 2019, at the Moscone Center in San Francisco, California. More than 11,000 leading physicians, scientists and health care professionals from around the world are expected to convene at the Scientific Sessions to unveil cutting-edge research, treatment recommendations and advances toward a cure for diabetes. During the five-day meeting, attendees will receive exclusive access to more than 850 presentations and 2,000 original research presentations, participate in provocative and engaging exchanges with leading diabetes experts, and can earn Continuing Medical Education (CME) or Continuing Education (CE) credits for educational sessions. The program is grouped into eight thematic areas: Acute and Chronic Complications; Behavioral Medicine, Clinical Nutrition, Education and Exercise; Clinical Diabetes/Therapeutics; Epidemiology/Genetics; Immunology/Transplantation; Insulin Action/Molecular Metabolism; Integrated Physiology/Obesity; and Islet Biology/Insulin Secretion. Gretchen Youssef, MS, RDN, CDE, President of Health Care and Education, will deliver her address, “It’s All about Access!,” on Saturday, June 8, and Louis H. Philipson, MD, PhD, FACP, President of Medicine and Science, will address attendees on Sunday, June 9. Join the Scientific Sessions conversation on social media using #ADA2019.
About the American Diabetes Association
Approximately every 21 seconds, someone in the United States is diagnosed with diabetes. Nearly half of the American adult population has diabetes or prediabetes, and more than 30 million adults and children are living with the disease. The American Diabetes Association (ADA) is the nation’s leading voluntary health organization on a mission to prevent and cure diabetes, as well as improve the lives of all people affected by the disease. For nearly 80 years, the ADA has driven discovery by funding research to treat, manage and prevent all types of diabetes, while working relentlessly for a cure. Magnifying the urgency of this epidemic, the ADA works to safeguard policies and programs that protect people with the illness, those at risk of developing diabetes and the health care professionals who serve them by initiating programs, advocacy and education efforts that can lead to improved health outcomes and quality of life.